Olr707 inhibitors represent a class of chemical compounds that specifically target the olfactory receptor 707 (Olr707), a protein found within the olfactory system responsible for detecting odor molecules. These inhibitors interact with the Olr707 receptor at the molecular level, typically binding to its active site or altering its conformation, thereby modulating its activity. The intricate interaction between these inhibitors and Olr707 involves a range of binding mechanisms, including hydrogen bonding, van der Waals forces, and hydrophobic interactions. The structure-activity relationship (SAR) studies of Olr707 inhibitors provide insight into the molecular features essential for high-affinity binding and effective inhibition, revealing the importance of specific functional groups and molecular geometries.
The development and study of Olr707 inhibitors involve advanced techniques in chemical synthesis and analytical chemistry. Researchers employ methods such as high-throughput screening (HTS) to identify potential inhibitors from vast chemical libraries, followed by rigorous characterization using techniques like nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography. Computational modeling and molecular docking studies further enhance understanding of the binding interactions at an atomic level. By elucidating the precise binding modes and conformational changes induced by these inhibitors, scientists gain valuable insights into the fundamental processes governing olfactory signal transduction. The study of Olr707 inhibitors not only advances the knowledge of olfactory receptor function but also contributes to the broader field of sensory biology, providing a deeper comprehension of how organisms perceive and interpret chemical signals in their environment.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Exemestane | 107868-30-4 | sc-203045 sc-203045A | 25 mg 100 mg | $134.00 $411.00 | ||
Aromatase inhibitor, potentially affecting estrogen synthesis and related signaling proteins. | ||||||
Raloxifene | 84449-90-1 | sc-476458 | 1 g | $802.00 | 3 | |
Selective estrogen receptor modulator, potentially influencing proteins in estrogen receptor signaling pathways. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Dual inhibitor of EGFR and HER2, potentially affecting proteins in associated signaling pathways. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
MEK inhibitor, potentially disrupting proteins in the MAPK/ERK pathway. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $29.00 $82.00 $420.00 $1897.00 $3021.00 | 5 | |
MEK inhibitor, potentially affecting proteins involved in the MAPK/ERK pathway. | ||||||
Pazopanib | 444731-52-6 | sc-396318 sc-396318A | 25 mg 50 mg | $130.00 $182.00 | 2 | |
Inhibits VEGF receptors, potentially affecting proteins involved in angiogenesis and tumor growth. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
EGFR tyrosine kinase inhibitor, potentially affecting proteins in the EGFR signaling pathway. | ||||||
Sotrastaurin | 425637-18-9 | sc-474229 sc-474229A | 5 mg 10 mg | $300.00 $540.00 | ||
Protein kinase C inhibitor, potentially influencing proteins in cell signaling pathways. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
HDAC inhibitor, potentially impacting gene expression and chromatin remodeling proteins. | ||||||
Apalutamide | 956104-40-8 | sc-507442 | 5 mg | $290.00 | ||
Androgen receptor antagonist, potentially affecting proteins in androgen receptor signaling pathways. | ||||||